Padlock Therapeutics Appoints Director Of Biology
This article was originally published in Scrip
Padlock Therapeutics, a company focused on autoimmune diseases, has appointed one of its scientific co-founders, Kerri Mowen, to the newly created position of director of biology. Mowen is an expert in the biology of protein-arginine deiminase (PAD) enzymes and will direct a team of biologists in a Padlock location as a resident company at the Johnson & Johnson Innovation JLABS incubator in San Diego.
Register for our free email digests: